Swiss National Bank - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 65 filers reported holding UROGEN PHARMA LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2022$417,0000.0%47,900
+9.1%
0.00%
Q4 2021$417,000
-43.5%
43,9000.0%0.00%
Q3 2021$738,000
+10.1%
43,9000.0%0.00%
Q2 2021$670,000
-19.1%
43,900
+3.3%
0.00%
-100.0%
Q1 2021$828,000
+8.1%
42,5000.0%0.00%0.0%
Q4 2020$766,000
-6.6%
42,5000.0%0.00%0.0%
Q3 2020$820,000
-21.2%
42,500
+6.8%
0.00%0.0%
Q2 2020$1,040,000
+69.1%
39,800
+15.4%
0.00%0.0%
Q1 2020$615,000
-45.8%
34,500
+1.5%
0.00%0.0%
Q4 2019$1,135,000
+41.7%
34,000
+1.2%
0.00%0.0%
Q3 2019$801,000
-30.8%
33,600
+4.3%
0.00%0.0%
Q2 2019$1,157,000
-2.7%
32,2000.0%0.00%0.0%
Q1 2019$1,189,000
+51.7%
32,200
+76.9%
0.00%0.0%
Q4 2018$784,000
-3.4%
18,200
+5.8%
0.00%0.0%
Q3 2018$812,000
-5.1%
17,2000.0%0.00%0.0%
Q2 2018$856,00017,2000.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2018
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 789,297$39,275,00060.44%
Wildcat Capital Management, LLC 251,459$12,513,0009.57%
Consonance Capital Management LP 1,487,491$74,018,0004.77%
MENORA MIVTACHIM HOLDINGS LTD. 2,499,870$124,394,0003.53%
MEITAV INVESTMENT HOUSE LTD 509,355$29,967,0001.34%
DSAM Partners (London) Ltd 127,588$6,349,0001.28%
SHIKIAR ASSET MANAGEMENT INC 48,125$2,395,0001.00%
BANK HAPOALIM BM 67,125$3,340,0000.91%
HIGHLINE CAPITAL MANAGEMENT, L.P. 331,900$16,515,0000.55%
Clal Insurance Enterprises Holdings Ltd 310,000$15,426,0000.40%
View complete list of UROGEN PHARMA LTD shareholders